Morgan Stanley’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-591,380
| Closed | -$3.45M | – | 7928 |
|
|
2022
Q4 | $3.45M | Sell |
591,380
-378,037
| -39% | -$1.99M | ﹤0.01% | 4059 |
|
|
2022
Q3 | $6.5M | Buy |
969,417
+257,208
| +36% | +$1.56M | ﹤0.01% | 3436 |
|
|
2022
Q2 | $3M | Buy |
712,209
+644,102
| +946% | +$2.55M | ﹤0.01% | 4209 |
|
|
2022
Q1 | $229K | Sell |
68,107
-210,629
| -76% | -$668K | ﹤0.01% | 5849 |
|
|
2021
Q4 | $878K | Buy |
278,736
+79,865
| +40% | +$266K | ﹤0.01% | 5166 |
|
|
2021
Q3 | $651K | Sell |
198,871
-136,367
| -41% | -$478K | ﹤0.01% | 5335 |
|
|
2021
Q2 | $1.41M | Buy |
335,238
+290,722
| +653% | +$1.23M | ﹤0.01% | 4874 |
|
|
2021
Q1 | $222K | Sell |
44,516
-1,302
| -3% | -$10.5K | ﹤0.01% | 5606 |
|
|
2020
Q4 | $580K | Buy |
45,818
+20,369
| +80% | +$232K | ﹤0.01% | 4988 |
|
|
2020
Q3 | $250K | Sell |
25,449
-1,601
| -6% | -$15.8K | ﹤0.01% | 4989 |
|
|
2020
Q2 | $269K | Buy |
27,050
+9,571
| +55% | +$91.8K | ﹤0.01% | 4936 |
|
|
2020
Q1 | $154K | Sell |
17,479
-44,198
| -72% | -$436K | ﹤0.01% | 4988 |
|
|
2019
Q4 | $569K | Sell |
61,677
-114,189
| -65% | -$809K | ﹤0.01% | 4854 |
|
|
2019
Q3 | $1.03M | Buy |
175,866
+156,512
| +809% | +$1.66M | ﹤0.01% | 4279 |
|
|
2019
Q2 | $233K | Buy |
19,354
+6,389
| +49% | +$68.7K | ﹤0.01% | 4958 |
|
|
2019
Q1 | $156K | Sell |
12,965
-24,434
| -65% | -$360K | ﹤0.01% | 5190 |
|
|
2018
Q4 | $469K | Sell |
37,399
-68,905
| -65% | -$951K | ﹤0.01% | 4827 |
|
|
2018
Q3 | $1.58M | Buy |
106,304
+24,361
| +30% | +$383K | ﹤0.01% | 4185 |
|
|
2018
Q2 | $1.38M | Sell |
81,943
-7,915
| -9% | -$154K | ﹤0.01% | 4397 |
|
|
2018
Q1 | $2.06M | Sell |
89,858
-98,175
| -52% | -$2.18M | ﹤0.01% | 3992 |
|
|
2017
Q4 | $4.87M | Buy |
188,033
+114,481
| +156% | +$2.31M | ﹤0.01% | 3138 |
|
|
2017
Q3 | $1.08M | Sell |
73,552
-10,259
| -12% | -$149K | ﹤0.01% | 4368 |
|
|
2017
Q2 | $1.17M | Buy |
83,811
+38,193
| +84% | +$563K | ﹤0.01% | 4254 |
|
|
2017
Q1 | $779K | Sell |
45,618
-84,678
| -65% | -$1.02M | ﹤0.01% | 4564 |
|
|
2016
Q4 | $1.34M | Buy |
130,296
+32,931
| +34% | +$301K | ﹤0.01% | 4242 |
|
|
2016
Q3 | $985K | Sell |
97,365
-56,474
| -37% | -$617K | ﹤0.01% | 4054 |
|
|
2016
Q2 | $1.73M | Sell |
153,839
-115,277
| -43% | -$1.47M | ﹤0.01% | 3539 |
|
|
2016
Q1 | $3.68M | Buy |
269,116
+90,614
| +51% | +$1.3M | ﹤0.01% | 2801 |
|
|
2015
Q4 | $3.39M | Sell |
178,502
-191,724
| -52% | -$4.17M | ﹤0.01% | 3042 |
|
|
2015
Q3 | $6.95M | Buy |
370,226
+361,203
| +4,003% | +$6.14M | ﹤0.01% | 2339 |
|
|
2015
Q2 | $134K | Sell |
9,023
-5,500
| -38% | -$83.8K | ﹤0.01% | 5439 |
|
|
2015
Q1 | $220K | Buy |
14,523
+11,305
| +351% | +$158K | ﹤0.01% | 5158 |
|
|
2014
Q4 | $43K | Hold |
3,218
| – | – | ﹤0.01% | 5857 |
|
|
2014
Q3 | $41K | Sell |
3,218
-7,710
| -71% | -$74.8K | ﹤0.01% | 5796 |
|
|
2014
Q2 | $111K | Sell |
10,928
-53,125
| -83% | -$513K | ﹤0.01% | 5451 |
|
|
2014
Q1 | $861K | Buy |
+64,053
| New | +$904K | ﹤0.01% | 4120 |
|
Morgan Stanley's CNCE Position: Q1 2023 in Review
Morgan Stanley sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 591,380 shares — an estimated $3.45M sold.
Morgan Stanley first reported a position in CNCE in Q1 2014 and held it in 36 quarters. The position peaked at $6.95M in Q3 2015. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Morgan Stanley reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Morgan Stanley sold 591,380 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $3.45M.
- Morgan Stanley first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 36 quarters.
- Morgan Stanley's Concert Pharmaceuticals, Inc. position peaked at $6.95M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.